What is a tumor board and should my Desmoid Tumors case be reviewed by one

Desmoid_tumorsMay 23, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Tumor Boards and Desmoid Tumors

What Is a Tumor Board?

A tumor board (also called a multidisciplinary tumor conference or case conference) is a meeting where a team of cancer specialists from different fields reviews individual patient cases together. Think of it as a "second opinion by committee."

Who typically participates:

  • Medical oncologists (cancer medicine doctors)
  • Surgical oncologists (cancer surgeons)
  • Radiation oncologists (radiation specialists)
  • Pathologists (doctors who examine tissue samples)
  • Radiologists (imaging specialists)
  • Other specialists relevant to your cancer type

What they do:

  • Review your imaging scans, pathology reports, and medical history
  • Discuss treatment options based on current evidence
  • Recommend an integrated treatment plan
  • Identify clinical trials you might be eligible for
  • Ensure nothing is missed in your diagnosis or staging

Should Your Desmoid Tumor Case Be Reviewed?

Yes, absolutely. Here's why tumor boards are particularly valuable for desmoid tumors:

Why Desmoid Tumors Benefit from Tumor Board Review:

  1. Rarity and Complexity: Desmoid tumors are rare, and treatment approaches have evolved significantly. Not all oncologists see them regularly, so a multidisciplinary team brings diverse expertise.

  2. Multiple Treatment Options: Unlike some cancers with a single standard approach, desmoid tumors may be managed with:

    • Active surveillance (watching and waiting)
    • Surgery
    • Radiation therapy
    • Systemic therapy (chemotherapy, targeted therapy, or hormone therapy)
    • Combination approaches
  3. Personalized Decision-Making: Your specific situation—tumor location, size, growth rate, symptoms, and your overall health—requires careful consideration. A tumor board can weigh these factors comprehensively.

  4. Access to Latest Evidence: Tumor boards stay current with emerging research and clinical trials specific to desmoid tumors.

Questions to Ask Your Healthcare Team

  1. "Can my case be reviewed by a tumor board?" Most major cancer centers have them, and many will review cases even if you're not treated there.

  2. "What specific aspects of my case would benefit most from multidisciplinary review?" (This helps you understand what the team will focus on.)

  3. "Will the tumor board recommendations be documented in writing for me to review?"

  4. "Are there any clinical trials for desmoid tumors that the tumor board might identify as options for me?"

  5. "How will the tumor board's recommendations be communicated to my primary oncologist, and how will we decide on the final treatment plan?"

How to Access a Tumor Board

  • Ask your oncologist directly if your case can be presented
  • Contact major cancer centers (many offer tumor board reviews for outside patients)
  • Look for specialized centers that focus on sarcomas or rare tumors—they often have robust tumor board programs
  • Check if your current hospital has a tumor board and request your case be included

Important Note

The personalized treatment recommendations discussed in the CancerPatientLab webinars on precision medicine highlight how important it is to have your specific tumor characteristics reviewed by experts. As mentioned in the webinar on "Identifying Personalized Treatment Recommendations," modern cancer care increasingly relies on understanding your tumor's unique features—something a multidisciplinary tumor board is well-positioned to evaluate comprehensively.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: